Treatment typically provided for comorbid anxiety disorders
L. S. Meredith, C. D. Sherbourne, C. A. Jackson, P. Camp and K. B. Wells
RAND Health Program, Santa Monica, Calif., USA.
OBJECTIVE: To study whether the extent and type of treatment for comorbid
anxiety disorders varies for patients with depression, hypertension,
diabetes, and heart disease treated by general medical clinicians. METHODS:
Data are from 2189 general medical patients with and without comorbid
anxiety disorders in the Medical Outcomes Study. Treatment data were based
on clinician reports of counseling provided during a visit and patient
reports of recent medication use. RESULTS: Patients with comorbid anxiety
disorders were more likely to receive treatments for anxiety disorders than
those without anxiety disorders. Among those with anxiety disorders, the
use of psychosocial counseling and psychotropic medication was greater for
patients with depression than for patients without depression who had
chronic medical conditions. Minor tranquilizers were used more commonly
than antidepressants, regardless of the type of comorbid condition. Among
patients with anxiety disorders, those visiting medical subspecialists were
more likely to use minor tranquilizers than those visiting family
practitioners or internists. Patients of family physicians with chronic
medical conditions (but not with depression) were less likely than similar
patients of internists to use minor tranquilizers whether or not anxiety
disorders were present. CONCLUSIONS: Anxiety disorders co-occurring with
another disease (medical illness or depression) increases the likelihood of
counseling and the use of psychotropic medication in the general medical
sector. Patients with a chronic medical illness with or without comorbid
anxiety disorders visiting family physicians are less likely to use minor
tranquilizers than those visiting subspecialists or internists.
Quality of Care for Primary Care Patients With Anxiety Disorders
Stein et al.
Am. J. Psychiatry 2004;161:2230-2237.
ABSTRACT
| FULL TEXT
Moving Treatment Research From Clinical Trials to the Real World
Roy-Byrne et al.
Focus 2004;2:410-415.
ABSTRACT
| FULL TEXT
Panic disorder: Psychopathology, medical management and dental implications
FRIEDLANDER et al.
Journal of the American Dental Association 2004;135:771-778.
ABSTRACT
| FULL TEXT
Moving Treatment Research From Clinical Trials to the Real World
Roy-Byrne et al.
Psychiatr. Serv. 2003;54:327-332.
ABSTRACT
| FULL TEXT
Cost-effectiveness and Cost Offset of a Collaborative Care Intervention for Primary Care Patients With Panic Disorder
Katon et al.
Arch Gen Psychiatry 2002;59:1098-1104.
ABSTRACT
| FULL TEXT
A Randomized Effectiveness Trial of Collaborative Care for Patients With Panic Disorder in Primary Care
Roy-Byrne et al.
Arch Gen Psychiatry 2001;58:869-876.
ABSTRACT
| FULL TEXT
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Walkup et al.
NEJM 2001;344:1279-1285.
ABSTRACT
| FULL TEXT
Development of a Brief Diagnostic Screen for Panic Disorder in Primary Care
Stein et al.
Psychosom. Med. 1999;61:359-364.
ABSTRACT
| FULL TEXT
